AZIN1

Gene symbol AZIN1
Aliases -
Protein Name Antizyme inhibitor 1 protein
Function Antizyme inhibitor (AZI) protein that positively regulates ornithine decarboxylase (ODC) activity and polyamine uptake. The wild-type AZIN1 could promote the tumorigenicity, the edited AZIN1 promotes cell proliferation and possibly the Hepatocellular Carcinoma onset and progression.
Species Human
Editing Sites 2
Disease Hepatocellular Carcinoma; Esophageal Squamous Cell Carcinoma;
Description The edited AZIN1 promotes cell proliferation and possibly the Hepatocellular Carcinoma onset and progression. The wild-type AZIN1 could promote the tumorigenicity, the edited AZIN1 conferred gain-of-function phenotypes that were manifested by more aggressive behaviors during Esophageal Squamous Cell Carcinoma progression.
RADR RADAR
REDIportal REDI portal
External links O14977(Uniport); NM_015878 (NM id); 51582 (NCBI gene id); GeneCard; GTEx
Sequence

Editing sites

Enzyme Editing type Region AA Seq Position NT Seq Position Codon Change Amino Acid Change Molecular Consequence Editing Level Tissue Interaction Editing Effect Phenotype Disease name PMID
  • ADAR1
A-to-I CDS 367 1872 AGC->GGC S->G Nonsynonymous substitution Present Liver Neutralize the antizyme-mediated degradation of ODC and CCND1 Edited AZIN1 promotes cell proliferation and possibly the HCC onset and progression. Promote tumor cell proliferation
  • ADAR1
A-to-I CDS 367 1872 AGC->GGC S->G Nonsynonymous substitution Present Esophageal Neutralize the antizyme-mediated degradation of ODC and CCND1 The edited AZIN1 conferred gain-of-function phenotypes that are manifested by more aggressive behaviors during ESCC progression. Promote aggressive behaviors in tumor progression
  • ADAR1
A-to-I NA NA NA NA NA mRNA expression change Increased cancer-associated fibroblasts NA mRNA expression change Enhanced the invasive potential of fibroblasts
  • ADAR1
A-to-I NA NA NA NA NA mRNA expression change Increased gastric tissues NA mRNA expression change Hyperediting status of AZIN1 RNA was an independent risk factor for lymph node metastasis